表紙
市場調查報告書
商品編碼
1023457

非口服營養的全球市場 (2021-2027年):市場預測 (各成分、消費者、終端用戶)、COVID-19的影響、地區的展望、用途的潛在性、價格趨勢、市場佔有率

Parenteral Nutrition Market Size By Composition, By Consumer, By End-use, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027

出版日期: | 出版商: Global Market Insights Inc. | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

非口服營養的市場,由於早產兒生產的全球性增加等,預計到2027年顯示大幅度的成長。

還有慢性疾病增加預計也更加促進在預測期間內的成長。

各成分中,油脂的部門2020年表現9億8600萬美元的規模,在預測期間內也預計顯示強勢成長。還有各消費者中,成人的部門2020年顯示30億1000萬美元的收益規模,由於成人的慢性疾病增加和老年人口的擴大,預計至2027年以穩定的步調成長。

本報告提供全球非口服營養的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的變化、預測,成分、消費者、終端用戶、地區/主要國家等各種區分的明細,競爭環境,市場佔有率,主要企業簡介等彙整資訊。

第1章 調查手法

第2章 摘要整理

第3章 產業考察

  • 產業的分類
  • 產業形勢
  • 對產業的影響要素
    • 成長要素
    • 潛在的風險&課題
  • 成長可能性
  • COVID-19:影響分析
  • 競爭情形
  • PESTEL分析

第4章 市場分析、預測:各成分

  • 氨基酸
  • 脂肪
  • 碳水化合物
  • 微量礦物質
  • 維他命
  • 礦物質
  • 其他

第5章 市場分析、預測:各消費者

  • 嬰幼兒
  • 成人

第6章 市場分析、預測:各終端用戶

  • 醫院
  • 診所
  • 居家醫療
  • 其他

第7章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第8章 企業簡介

  • 競爭儀表板
  • Aculife Healthcare
  • Amanta Healthcare
  • Anhui Medipharm Co , Ltd
  • B Braun Melsungen AG
  • Baxter International, Inc
  • Fresenius Kabi AG
  • Grifols International S A
  • Guangzhou Green Cross Pharmaceutical Co , Ltd
  • ICU Medical
  • Otsuka Pharmaceutical Factory, Inc.(OTSUKA HOLDINGS CO., LTD.)
  • Sichuan Kelun Pharmaceutical Co. Ltd.
  • Xi'an Libang Enterprises
目錄
Product Code: 3216

The parenteral nutrition market is set to witness substantial growth by 2027 owing to increasing number of pre-mature births across the globe. Additionally, mounting prevalence of chronic diseases is expected to further support market growth through the forecast period.

Parenteral nutrition involves administering patients with vital life supporting nutrients through the veins and bypassing the gastrointestinal tract. This method of feeding is typically offered to premature newborns or individuals who are incapable of absorbing necessary nutrients from their food to sustain. Notably, growing geriatric population, rising incidences of metabolic disorders, and pre-mature infants globally have played a vital role in fueling market demand.

Moreover, major industry participants are employing lucrative techniques to tap into emerging marketplaces through acquisitions, alliances, mergers, and product launches, which has positively impacted the global business landscape. For instance, in November 2020, Grifols, a major healthcare firm, inked a strategic alliance with B. Braun Melsungen AG, a leading medical devices company, to enhance therapy safety and pharmacy manufacturing output.

Citing another instance, in August 2021, Baxter International Inc., a prominent medical products manufacturer, collaborated with Amazon Web Services (AWS) to facilitate its digital transformation by leveraging cloud technology. Subsequently, technological integration and expansion strategies implemented by industry players have augmented market expansion.

The parenteral nutrition market has been categorized based on composition, end-use, consumer, and region. On the basis of composition, the market has further been segmented into fats, amino acids, minerals, trace elements, carbohydrates, vitamins, and others.

The fats composition segment garnered a valuation of around USD 986 million in 2020 and is calculated to grow at a robust pace over 2021-2027 due to numerous applications and favorable clinical outcomes related with the use of fats in parenteral nutrition products.

In terms of consumer, the market has been differentiated into children & newborn and adults. In 2020, the parenteral nutrition market from the adults consumer segment held a sizable revenue of about USD 3,010 million and is estimated to grow at a steady pace through 2027 driven by rising incidences of chronic diseases in adults and expanding geriatric population.

With respect to end-use, the market has been bifurcated into homecare, hospitals, clinics, and others. The homecare end-use segment is anticipated to exceed a valuation of USD 1,148 million by 2027, progressing at a notable CAGR over the forecast period. Surging prevalence of chronic conditions requiring long-term care, as along with cost-effectiveness and high patient convenience associated with homecare, is likely to bolster segmental adoption through the following years.

From the regional point of view, the Middle East & Africa parenteral nutrition market attained a considerable market share in 2020 and is slated to surpass a valuation of USD 468 million by the end of 2027. Increased occurrences of malnutrition and soaring number of preterm births across various countries in MEA are speculated to foster regional market outlook in the future.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definition
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Parenteral nutrition industry 360 degree synopsis, 2016 - 2027 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Composition trends
    • 2.1.3 Consumer trends
    • 2.1.4 End-use trends
    • 2.1.5 Regional trends

Chapter 3 Parenteral Nutrition Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2016 - 2027 (USD Million)
  • 3.3 Industry impact factors
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing metabolic disorders and other chronic diseases
      • 3.3.1.2 Growing malnutrition across the globe
      • 3.3.1.3 Rise in geriatric population
      • 3.3.1.4 Increasing rate of pre-mature birth & birth rate
      • 3.3.1.5 Growing adoption of home healthcare settings in developed countries
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Lack of clinical evidence to support novel technology
      • 3.3.2.2 Lack of awareness in developing countries
  • 3.4 Growth potential analysis
    • 3.4.1 By composition
    • 3.4.2 By consumer
    • 3.4.3 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2020
    • 3.7.1 Competitive matrix analysis, 2020
  • 3.8 PESTEL analysis

Chapter 4 Parenteral Nutrition Market, By Composition

  • 4.1 Key segment trends
  • 4.2 Amino acids
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Fats
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.4 Carbohydrates
    • 4.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.5 Trace elements
    • 4.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.6 Vitamins
    • 4.6.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.7 Minerals
    • 4.7.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.8 Others
    • 4.8.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Parenteral Nutrition Market, By Consumer

  • 5.1 Key segment trends
  • 5.2 Children and newborns
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Adults
    • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 6 Parenteral Nutrition Market, By End-use

  • 6.1 Key segment trends
  • 6.2 Hospitals
    • 6.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.3 Clinics
    • 6.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.4 Homecare
    • 6.4.1 Market size, by region, 2016 - 2027 (USD Million)
  • 6.5 Others
    • 6.5.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 7 Parenteral Nutrition Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.2.2 Market size, by composition, 2016 - 2027 (USD Million)
    • 7.2.3 Market size, by consumer, 2016 - 2027 (USD Million)
    • 7.2.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.2.5.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.2.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.2.6.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.2.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.3.2 Market size, by composition, 2016 - 2027 (USD Million)
    • 7.3.3 Market size, by consumer, 2016 - 2027 (USD Million)
    • 7.3.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.3.5.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.3.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.3.6 France
      • 7.3.6.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.3.6.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.3.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.3.7 UK
      • 7.3.7.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.3.7.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.3.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.3.8 Spain
      • 7.3.8.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.3.8.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.3.8.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.3.9 Italy
      • 7.3.9.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.3.9.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.3.9.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.4.2 Market size, by composition, 2016 - 2027 (USD Million)
    • 7.4.3 Market size, by consumer, 2016 - 2027 (USD Million)
    • 7.4.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.4.5.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.4.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.4.6.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.4.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.4.7.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.4.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.4.8 Australia
      • 7.4.8.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.4.8.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.4.8.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.4.9 South Korea
      • 7.4.9.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.4.9.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.4.9.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.5.2 Market size, by composition, 2016 - 2027 (USD Million)
    • 7.5.3 Market size, by consumer, 2016 - 2027 (USD Million)
    • 7.5.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.5.5.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.5.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.5.6.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.5.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.5.7.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.5.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
  • 7.6 Middle East & Africa
    • 7.6.1 Market size, by country, 2016 - 2027 (USD Million)
    • 7.6.2 Market size, by composition, 2016 - 2027 (USD Million)
    • 7.6.3 Market size, by consumer, 2016 - 2027 (USD Million)
    • 7.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.6.5.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.6.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.6.6.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.6.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 7.6.7 UAE
      • 7.6.7.1 Market size, by composition, 2016 - 2027 (USD Million)
      • 7.6.7.2 Market size, by consumer, 2016 - 2027 (USD Million)
      • 7.6.7.3 Market size, by end-use, 2016 - 2027 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Competitive dashboard, 2020
  • 8.2 Aculife Healthcare
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 Amanta Healthcare
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Anhui Medipharm Co , Ltd
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 B Braun Melsungen AG
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Baxter International, Inc
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 Fresenius Kabi AG
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Grifols International S A
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Guangzhou Green Cross Pharmaceutical Co , Ltd
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 ICU Medical
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 Otsuka Pharmaceutical Factory, Inc. (OTSUKA HOLDINGS CO., LTD.)
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis
  • 8.12 Sichuan Kelun Pharmaceutical Co. Ltd.
    • 8.12.1 Business overview
    • 8.12.2 Financial data
    • 8.12.3 Product landscape
    • 8.12.4 Strategic outlook
    • 8.12.5 SWOT analysis
  • 8.13 Xi'an Libang Enterprises
    • 8.13.1 Business overview
    • 8.13.2 Financial data
    • 8.13.3 Product landscape
    • 8.13.4 Strategic outlook
    • 8.13.5 SWOT analysis

Data Tables

  • TABLE 1. Global parenteral nutrition market, 2016 - 2020 (USD Million)
  • TABLE 2. Global parenteral nutrition market, 2021 - 2027 (USD Million)
  • TABLE 3. Global parenteral nutrition market, by composition, 2016 - 2020 (USD Million)
  • TABLE 4. Global parenteral nutrition market, by composition, 2021 - 2027 (USD Million)
  • TABLE 5. Global parenteral nutrition market, by consumer, 2016 - 2020 (USD Million)
  • TABLE 6. Global parenteral nutrition market, by consumer, 2021 - 2027 (USD Million)
  • TABLE 7. Global parenteral nutrition market, by end-use, 2016 - 2020 (USD Million)
  • TABLE 8. Global parenteral nutrition market, by end-use, 2021 - 2027 (USD Million)
  • TABLE 9. Global parenteral nutrition market, by region, 2016 - 2020 (USD Million)
  • TABLE 10. Global parenteral nutrition market, by region, 2021 - 2027 (USD Million)
  • TABLE 11. Industry impact forces
  • TABLE 12. Amino acids market size, by region, 2016 - 2020 (USD Million)
  • TABLE 13. Amino acids market size, by region, 2021 - 2027 (USD Million)
  • TABLE 14. Fats market size, by region, 2016 - 2020 (USD Million)
  • TABLE 15. Fats market size, by region, 2021 - 2027 (USD Million)
  • TABLE 16. Carbohydrates market size, by region, 2016 - 2020 (USD Million)
  • TABLE 17. Carbohydrates market size, by region, 2021 - 2027 (USD Million)
  • TABLE 18. Trace elements market size, by region, 2016 - 2020 (USD Million)
  • TABLE 19. Trace elements market size, by region, 2021 - 2027 (USD Million)
  • TABLE 20. Vitamins market size, by region, 2016 - 2020 (USD Million)
  • TABLE 21. Vitamins market size, by region, 2021 - 2027 (USD Million)
  • TABLE 22. Minerals market size, by region, 2016 - 2020 (USD Million)
  • TABLE 23. Minerals market size, by region, 2021 - 2027 (USD Million)
  • TABLE 24. Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 25. Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 26. Children and newborns market size, by region, 2016 - 2020 (USD Million)
  • TABLE 27. Children and newborns market size, by region, 2021 - 2027 (USD Million)
  • TABLE 28. Adults market size, by region, 2016 - 2020 (USD Million)
  • TABLE 29. Adults market size, by region, 2021 - 2027 (USD Million)
  • TABLE 30. Hospitals market size, by region, 2016 - 2020 (USD Million)
  • TABLE 31. Hospitals market size, by region, 2021 - 2027 (USD Million)
  • TABLE 32. Clinics market size, by region, 2016 - 2020 (USD Million)
  • TABLE 33. Clinics market size, by region, 2021 - 2027 (USD Million)
  • TABLE 34. Homecare market size, by region, 2016 - 2020 (USD Million)
  • TABLE 35. Homecare market size, by region, 2021 - 2027 (USD Million)
  • TABLE 36. Others market size, by region, 2016 - 2020 (USD Million)
  • TABLE 37. Others market size, by region, 2021 - 2027 (USD Million)
  • TABLE 38. North America parenteral nutrition market size, by country, 2016 - 2020 (USD Million)
  • TABLE 39. North America parenteral nutrition market size, by country, 2021 - 2027 (USD Million)
  • TABLE 40. North America parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 41. North America parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 42. North America parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 43. North America parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 44. North America parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 45. North America parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 46. U.S. parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 47. U.S. parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 48. U.S. parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 49. U.S. parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 50. U.S. parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 51. U.S. parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 52. Canada parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 53. Canada parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 54. Canada parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 55. Canada parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 56. Canada parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 57. Canada parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 58. Europe parenteral nutrition market size, by country, 2016 - 2020 (USD Million)
  • TABLE 59. Europe parenteral nutrition market size, by country, 2021 - 2027 (USD Million)
  • TABLE 60. Europe parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 61. Europe parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 62. Europe parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 63. Europe parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 64. Europe parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 65. Europe parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 66. Germany parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 67. Germany parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 68. Germany parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 69. Germany parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 70. Germany parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 71. Germany parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 72. France parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 73. France parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 74. France parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 75. France parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 76. France parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 77. France parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 78. UK parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 79. UK parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 80. UK parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 81. UK parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 82. UK parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 83. UK parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 84. Spain parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 85. Spain parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 86. Spain parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 87. Spain parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 88. Spain parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 89. Spain parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 90. Italy parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 91. Italy parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 92. Italy parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 93. Italy parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 94. Italy parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 95. Italy parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 96. Asia Pacific parenteral nutrition market size, by country, 2016 - 2020 (USD Million)
  • TABLE 97. Asia Pacific parenteral nutrition market size, by country, 2021 - 2027 (USD Million)
  • TABLE 98. Asia Pacific parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 99. Asia Pacific parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 100. Asia Pacific parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 101. Asia Pacific parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 102. Asia Pacific parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 103. Asia Pacific parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 104. China parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 105. China parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 106. China parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 107. China parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 108. China parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 109. China parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 110. Japan parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 111. Japan parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 112. Japan parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 113. Japan parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 114. Japan parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 115. Japan parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 116. India parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 117. India parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 118. India parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 119. India parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 120. India parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 121. India parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 122. Australia parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 123. Australia parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 124. Australia parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 125. Australia parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 126. Australia parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 127. Australia parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 128. South Korea parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 129. South Korea parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 130. South Korea parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 131. South Korea parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 132. South Korea parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 133. South Korea parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 134. Latin America parenteral nutrition market size, by country, 2016 - 2020 (USD Million)
  • TABLE 135. Latin America parenteral nutrition market size, by country, 2021 - 2027 (USD Million)
  • TABLE 136. Latin America parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 137. Latin America parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 138. Latin America parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 139. Latin America parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 140. Latin America parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 141. Latin America parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 142. Brazil parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 143. Brazil parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 144. Brazil parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 145. Brazil parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 146. Brazil parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 147. Brazil parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 148. Mexico parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 149. Mexico parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 150. Mexico parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 151. Mexico parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 152. Mexico parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 153. Mexico parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 154. Argentina parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 155. Argentina parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 156. Argentina parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 157. Argentina parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 158. Argentina parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 159. Argentina parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 160. MEA parenteral nutrition market size, by country, 2016 - 2020 (USD Million)
  • TABLE 161. MEA parenteral nutrition market size, by country, 2021 - 2027 (USD Million)
  • TABLE 162. MEA parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 163. MEA parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 164. MEA parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 165. MEA parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 166. MEA parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 167. MEA parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 168. South Africa parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 169. South Africa parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 170. South Africa parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 171. South Africa parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 172. South Africa parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 173. South Africa parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 174. Saudi Arabia parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 175. Saudi Arabia parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 176. Saudi Arabia parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 177. Saudi Arabia parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 178. Saudi Arabia parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 179. Saudi Arabia parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)
  • TABLE 180. UAE parenteral nutrition market size, by composition, 2016 - 2020 (USD Million)
  • TABLE 181. UAE parenteral nutrition market size, by composition, 2021 - 2027 (USD Million)
  • TABLE 182. UAE parenteral nutrition market size, by consumer, 2016 - 2020 (USD Million)
  • TABLE 183. UAE parenteral nutrition market size, by consumer, 2021 - 2027 (USD Million)
  • TABLE 184. UAE parenteral nutrition market size, by end-use, 2016 - 2020 (USD Million)
  • TABLE 185. UAE parenteral nutrition market size, by end-use, 2021 - 2027 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Data validation
  • FIG. 3 Parenteral nutrition industry, 360 degree synopsis, 2016-2027
  • FIG. 4 Industry segmentation
  • FIG. 5 Global parenteral nutrition market size, 2016 - 2027 (USD Million)
  • FIG. 6 Growth potential analysis, by composition
  • FIG. 7 Growth potential analysis, by consumer
  • FIG. 8 Growth potential analysis, by end-use
  • FIG. 9 Porter's analysis
  • FIG. 10 Competitive matrix analysis, 2020
  • FIG. 11 PESTEL analysis
  • FIG. 12 Key segment trends, by composition
  • FIG. 13 Key segment trends, by consumer
  • FIG. 14 Key segment trends, by end-use
  • FIG. 15 Key regional trends
  • FIG. 16 Competitive dashboard, 2020